Scancell to present six posters at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference To download click here
Antibody collaboration deal for Scancell CEO Cliff Holloway tells Proactive London why its antibody collaboration deal is significant and details how it complements Scancell's existing antibody technology. He also explains what is unique about Scancell's antibody pipeline.
Scancell signs first collaboration agreement for its new platform technology, AvidiMab™ To download click here